stoke therapeutics

stoke therapeutics

None

Chart

Detailed Quote

Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively restore protein levels.
Featured Articles and Interviews
A floating DNA double helix above a hand with a blue background.

Top 4 NASDAQ Genetics Stocks (Updated January 2026)

A floating DNA double helix above a hand with a blue background.

Top 5 NASDAQ Genetics Stocks (Updated January 2025)

Press Releases

NAVER, NVIDIA and Brookfield to Expand Korea's National AI Factory Infrastructure Buildout

Gold'n Futures Announces Appointment of Chief Executive Officer and Board Changes

The Conversation (0)